Index RUT P/E 27.81 EPS (ttm) 3.90 Insider Own 2.40% Shs Outstand 19.80M Perf Week 2.87%
Market Cap 2.03B Forward P/E 19.76 EPS next Y 5.49 Insider Trans -4.38% Shs Float 18.30M Perf Month 8.07%
Income 76.73M PEG 2.06 EPS next Q 1.14 Inst Own 94.54% Short Float / Ratio 1.34% / 2.13 Perf Quarter 7.66%
Sales 1.37B P/S 1.49 EPS this Y 39.21% Inst Trans -8.04% Short Interest 0.25M Perf Half Y 30.50%
Book/sh 29.51 P/B 3.68 EPS next Y 15.03% ROA 6.20% Target Price 131.00 Perf Year 39.37%
Cash/sh 0.50 P/C 216.44 EPS next 5Y 13.50% ROE 13.83% 52W Range 66.51 - 113.31 Perf YTD 49.46%
Dividend - P/FCF 14.73 EPS past 5Y - ROI 8.07% 52W High -4.24% Beta 0.59
Dividend % - Quick Ratio 1.53 Sales past 5Y 8.07% Gross Margin 28.21% 52W Low 63.15% ATR 2.70
Employees 5660 Current Ratio 1.53 Sales Q/Q 25.76% Oper. Margin 9.90% RSI (14) 63.40 Volatility 2.38% 3.03%
Optionable Yes Debt/Eq 0.74 EPS Q/Q 28.38% Profit Margin 5.60% Rel Volume 1.41 Prev Close 104.17
Shortable Yes LT Debt/Eq 0.72 Earnings Nov 02 AMC Payout 0.00% Avg Volume 115.48K Price 108.51
Recom 1.00 SMA20 3.85% SMA50 5.31% SMA200 21.09% Volume 162,482 Change 4.17%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-18-20 Upgrade The Benchmark Company
Hold → Buy
$64
May-01-20 Downgrade The Benchmark Company
Buy → Hold
Aug-05-19 Reiterated Barrington Research
Outperform
$57 → $68
May-02-19 Reiterated The Benchmark Company
Buy
$56 → $58
Sep-18-18 Reiterated The Benchmark Company
Buy
$52 → $54
Aug-28-18 Upgrade Barrington Research
Mkt Perform → Outperform
$55
Aug-01-18 Upgrade The Benchmark Company
Hold → Buy
$52
Sep-08-17 Upgrade William Blair
Mkt Perform → Outperform
May-23-17 Initiated The Benchmark Company
Hold
Mar-24-17 Upgrade Avondale
Mkt Perform → Mkt Outperform
Feb-21-17 Downgrade Barrington Research
Outperform → Mkt Perform
Aug-01-16 Reiterated Barrington Research
Outperform
$67 → $69
Feb-23-16 Reiterated Deutsche Bank
Buy
$65 → $60
Oct-26-15 Reiterated Barrington Research
Outperform
$82 → $64
Feb-25-15 Reiterated Deutsche Bank
Buy
$80 → $76
Jan-28-15 Reiterated Stifel
Buy
$75 → $80
Apr-30-14 Reiterated Stifel
Buy
$74 → $75
Nov-07-13 Reiterated Deutsche Bank
Buy
$60 → $63
Oct-16-13 Reiterated Deutsche Bank
Buy
$55 → $60
Jun-21-13 Initiated Stifel
Buy
$52
Show Previous Ratings
Nov-29-23 11:04PM
10:00AM
Nov-27-23 12:00PM
Nov-08-23 12:45PM
Nov-06-23 10:42AM
10:00AM
Loading…
10:00AM
Nov-02-23 06:33PM
05:52PM
(Associated Press Finance)
04:05PM
Oct-31-23 11:54AM
Oct-19-23 09:05AM
Oct-17-23 12:47PM
08:17AM
Oct-06-23 08:50AM
Oct-03-23 11:00AM
08:50AM
Loading…
Sep-20-23 08:50AM
Sep-19-23 09:00AM
Sep-18-23 10:00AM
Sep-15-23 08:22AM
06:00AM
Sep-08-23 08:23AM
Sep-06-23 09:40AM
07:56AM
Aug-15-23 09:07AM
Aug-14-23 08:08AM
Jul-29-23 10:26AM
Jul-28-23 09:11AM
(Thomson Reuters StreetEvents) +18.11%
Jul-27-23 05:55PM
04:43PM
04:05PM
09:05AM
Loading…
Jul-13-23 09:05AM
Jun-30-23 05:00AM
Jun-26-23 08:50AM
Jun-20-23 10:00AM
Jun-10-23 08:13AM
Jun-09-23 09:26AM
Jun-08-23 08:50AM
Jun-01-23 09:55AM
09:40AM
May-29-23 11:39AM
May-23-23 08:50AM
May-20-23 10:46AM
May-17-23 10:00AM
May-09-23 08:40AM
May-04-23 12:00PM
May-03-23 10:32AM
(Thomson Reuters StreetEvents) -12.01%
May-02-23 06:05PM
04:05PM
09:15AM
Apr-21-23 08:50AM
06:59AM
Apr-18-23 09:28AM
09:05AM
Apr-14-23 09:15AM
Apr-10-23 09:40AM
Apr-05-23 08:50AM
Mar-29-23 09:40AM
Mar-24-23 09:40AM
Mar-20-23 08:50AM
07:14AM
Mar-07-23 09:40AM
Mar-03-23 08:10PM
Mar-02-23 09:15AM
08:50AM
05:44AM
Mar-01-23 11:55AM
(Thomson Reuters StreetEvents) +16.17%
Feb-28-23 04:05PM
Feb-14-23 09:05AM
Jan-09-23 10:00AM
Dec-28-22 09:40AM
Dec-27-22 02:11PM
09:33AM
Dec-19-22 01:48PM
Dec-15-22 09:40AM
Dec-12-22 08:50AM
Dec-11-22 09:14AM
Dec-08-22 09:40AM
Dec-01-22 10:59AM
09:15AM
Nov-28-22 09:15AM
Nov-24-22 06:02AM
Nov-23-22 08:50AM
Nov-21-22 09:40AM
09:40AM
Nov-18-22 01:09PM
Nov-16-22 09:05AM
Nov-08-22 10:00AM
Nov-07-22 01:45PM
09:15AM
Nov-04-22 09:40AM
Nov-03-22 04:10PM
(Investor's Business Daily)
09:15AM
08:50AM
Nov-01-22 06:35PM
04:05PM
Oct-27-22 09:31AM
Oct-24-22 06:15PM
Oct-18-22 09:05AM
Oct-17-22 06:15PM
Oct-06-22 04:10PM
Huron Consulting Group, Inc. engages in the provision of technology, data, and analytics solutions. It operates through the following segments: Healthcare, Education, and Commercial. The Healthcare segment focuses on serving acute care providers including national and regional health systems, academic health systems, and community health systems, and public, children, and critical access hospitals, and non-acute care providers including physician practices and medical groups, payors, and long-term care or post-acute providers. The Education segment is involved in public and private colleges and universities, research institutes, and other education-related organizations. The Commercial segment includes industries outside of healthcare and education including financial services and energy and utilities. The company was founded in 2002 and is headquartered in Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Singh-Bushell Ekta Director Nov 27 Sale 105.95 5,976 633,138 13,209 Nov 29 11:47 AM MCCARTNEY JOHN Director Nov 06 Sale 101.80 300 30,540 58,119 Nov 08 12:04 PM Roth James H Director Nov 01 Sale 98.37 2,000 196,740 76,331 Nov 03 10:53 AM Zumwalt Debra Director Oct 03 Sale 103.17 259 26,721 25,221 Oct 05 09:29 AM Singh-Bushell Ekta Director Oct 03 Sale 103.17 192 19,809 19,185 Oct 05 09:25 AM Roth James H Director Oct 02 Sale 103.40 2,000 206,800 78,331 Oct 04 10:09 AM Roth James H Director Sep 01 Sale 100.07 2,000 200,140 80,331 Sep 06 11:43 AM Roth James H Director Aug 17 Sale 99.27 2,000 198,540 82,331 Aug 21 11:31 AM LOCKHART H EUGENE Director Aug 14 Sale 99.15 2,100 208,216 33,097 Aug 16 11:01 AM Zumwalt Debra Director Aug 10 Sale 98.15 259 25,421 25,480 Aug 14 09:34 AM Singh-Bushell Ekta Director Aug 08 Sale 100.69 192 19,332 19,377 Aug 10 09:42 AM SAWYER HUGH E III Director Aug 02 Sale 100.78 3,000 302,340 24,833 Aug 04 12:00 PM Featherstone Kyle Chief Acct Officer, Controller Aug 01 Sale 97.55 320 31,216 2,132 Aug 03 11:03 AM Kelly John D. EVP, CFO and Treasurer May 08 Buy 75.29 1,500 112,937 47,798 May 09 10:36 AM Hussey C. Mark CEO and President May 05 Buy 72.48 2,000 144,960 110,286 May 08 10:48 AM Zumwalt Debra Director Apr 05 Sale 79.98 282 22,554 23,642 Apr 07 11:11 AM LOCKHART H EUGENE Director Mar 07 Sale 78.41 2,855 223,854 33,100 Mar 09 11:30 AM LOCKHART H EUGENE Director Mar 06 Sale 80.06 952 76,222 35,955 Mar 08 10:35 AM Roth James H Director Jan 05 Option Exercise 39.19 6,054 237,256 101,284 Jan 09 02:46 PM Roth James H Director Jan 05 Sale 68.38 16,054 1,097,777 85,230 Jan 09 02:46 PM Zumwalt Debra Director Jan 04 Sale 72.61 282 20,476 23,924 Jan 06 09:21 AM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite
